---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-061203"
form_type: "8-K"
ticker: "TOVX"
cik: "0000894158"
company_name: "Theriva Biologics, Inc."
filed_at: "2025-06-20T23:59:59+00:00"
generated_at: "2026-05-19T02:20:36.024259+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Theriva Biologics files $2.5M at-the-market equity offering through A.G.P.

## Summary
- Up to $2,534,352 of common stock registered for sale via ATM method with A.G.P./Alliance Global Partners.
- Sales agent commission rate set at up to 3.0% of gross proceeds per share sold.
- No minimum sale requirement; agent uses commercially reasonable efforts on a principal or agency basis.
- Proceeds will be used for general corporate purposes; no escrow or trust arrangement.

## SEC filing metadata
- accession: 0001104659-25-061203
- form_type: 8-K
- ticker: TOVX
- cik: 0000894158
- company_name: Theriva Biologics, Inc.
- filed_at: 2025-06-20T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/894158/000110465925061203/0001104659-25-061203-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/894158/000110465925061203/tm2518362d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-061203
- JSON: https://secwatch.observer/filing/0001104659-25-061203.json
- Plain text: https://secwatch.observer/filing/0001104659-25-061203.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.